Suppr超能文献

定量检测肠活检组织中的巨细胞病毒 DNA 水平作为巨细胞病毒肠病的诊断工具。

Quantification of cytomegalovirus DNA levels in intestinal biopsies as a diagnostic tool for CMV intestinal disease.

机构信息

Institute of Virology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.

出版信息

J Clin Virol. 2009 Nov;46(3):254-8. doi: 10.1016/j.jcv.2009.08.008. Epub 2009 Sep 12.

Abstract

BACKGROUND

CMV intestinal disease (CMV-ID) is a serious complication in immunocompromised patients and mainly diagnosed by clinical, endoscopic and histopathologic findings, whereas qualitative CMV-PCR in tissue samples is not recommended for diagnosis due to its low positive predictive value (PPV).

OBJECTIVES

To study the interpretation and diagnostic use of CMV-quantification by PCR in intestinal tissue biopsies to recognize CMV-ID. To develop cut-off intestinal CMV-loads attributing illness to CMV.

STUDY DESIGN

CMV-genome copies in 163 biopsies from the lower intestinal tract of immunocompromised patients were determined by quantitative real-time PCR, normalized to the cell number, and retrospectively compared to histopathological analysis, clinical findings and occurrence of CMV-antigenemia. Two cut-off intestinal CMV-loads, cut-off(histo) and cut-off(clin), were defined using histopathological or clinical criteria as gold standard, respectively.

RESULTS

CMV was detected in 32.5% of biopsies with a more than six log range of CMV-concentrations (1 x 10(-4)-1.4 x 10(2)copies/cell). Notably, biopsies with histopathologically or clinically confirmed CMV-ID had a significantly higher CMV-load (p<0.001). Cut-off(histo) and cut-off(clin) were defined at the intestinal CMV-load of 0.14 and 0.01 copies/cell, respectively, and improved the PPV. However, cut-off(histo) showed a decreased sensitivity for clinically defined CMV-ID cases. Interestingly, many patients with CMV-ID showed no concomitant CMV-antigenemia, suggesting a localized intestinal CMV-replication.

CONCLUSIONS

Quantification of CMV in intestinal biopsies is a useful diagnostic tool allowing the definition of cut-off values that can predict CMV-ID more accurate than qualitative PCR results. Further prospective studies have to clarify wether these cut-offs can improve diagnostics and treatment of CMV-ID in day-to-day clinical practice.

摘要

背景

巨细胞病毒(CMV)肠道疾病(CMV-ID)是免疫功能低下患者的严重并发症,主要通过临床、内镜和组织病理学发现进行诊断,而组织样本中 CMV-PCR 的定性检测不推荐用于诊断,因为其阳性预测值(PPV)较低。

目的

研究肠组织活检中 CMV-PCR 定量检测的解释和诊断用途,以识别 CMV-ID。确定与 CMV 相关疾病的肠道 CMV 载量的截止值。

研究设计

通过实时定量 PCR 测定 163 例免疫功能低下患者下消化道活检组织中的 CMV 基因组拷贝数,按细胞数进行归一化,并与组织病理学分析、临床发现和 CMV 抗原血症的发生进行回顾性比较。使用组织病理学或临床标准作为金标准,分别定义两个肠道 CMV 载量截止值,截止值(组织学)和截止值(临床)。

结果

在 CMV 浓度对数范围超过 6 个对数级(1x10(-4)-1.4x10(2)拷贝/细胞)的 32.5%的活检组织中检测到 CMV。值得注意的是,具有组织病理学或临床证实的 CMV-ID 的活检组织具有明显更高的 CMV 载量(p<0.001)。截止值(组织学)和截止值(临床)分别定义为肠道 CMV 载量为 0.14 和 0.01 拷贝/细胞,可提高 PPV。然而,截止值(组织学)对临床上定义的 CMV-ID 病例的敏感性降低。有趣的是,许多 CMV-ID 患者没有同时出现 CMV 抗原血症,提示存在局部肠道 CMV 复制。

结论

肠活检组织中 CMV 的定量检测是一种有用的诊断工具,允许定义截止值,比定性 PCR 结果更能准确预测 CMV-ID。进一步的前瞻性研究需要阐明这些截止值是否可以改善 CMV-ID 在日常临床实践中的诊断和治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验